| 1 | 99 | inclusion criterion pharm. | telce | 8.03.2009 | 22:36 |
| 2 | 152 | Название фирмы pharm. | telce | 8.03.2009 | 0:36 |
| 6 | 78 | Multiple Unit Pellet System pharm. | telce | 3.03.2009 | 0:25 |
| 3 | 109 | named patient use pharm. | telce | 22.02.2009 | 22:51 |
| 1 | 144 | Class label on renal effects pharm. | telce | 22.02.2009 | 15:04 |
| 1 | 73 | diaphragm-like intestinal stricture med. | telce | 19.02.2009 | 19:48 |
| 2 | 462 | Ноттингемский профиль здоровья med. | telce | 16.02.2009 | 19:15 |
| 1 | 236 | pooled human liver microsomes pharm. | telce | 8.02.2009 | 19:21 |
| 1 | 78 | extract of liver pharm. | telce | 8.02.2009 | 13:51 |
| 4 | 250 | disposition study + химия pharm. | telce | 6.02.2009 | 1:06 |
| 3 | 277 | toxicity species pharm. | telce | 5.02.2009 | 20:26 |
| 5 | 806 | telemetered dogs pharm. | telce | 5.02.2009 | 12:18 |
| 6 | 186 | facility under contract pharm. | telce | 3.02.2009 | 23:47 |
| 1 | 106 | tabulated summary pharm. | telce | 3.02.2009 | 23:35 |
| 10 | 1208 | log-linear trapezoidal rule pharm. | telce | 3.02.2009 | 0:02 |
| 5 | 268 | translational sciences pharm. | telce | 2.02.2009 | 17:58 |
| 1 | 487 | non-clinical overview pharm. | telce | 2.02.2009 | 15:39 |
| 71 | aggregate and cumulative report med. | telce | 1.02.2009 | 0:38 | |
| 2 | 584 | HCP/ non-HCP med. | telce | 1.02.2009 | 0:07 |
| 2 | 1181 | solicited suspected report pharm. | telce | 31.01.2009 | 23:08 |
| 3 | 4560 | propensity study med. | telce | 29.01.2009 | 11:31 |
| 2 | 128 | CDS med. | telce | 23.01.2009 | 13:38 |
| 20 | 15373 | MD/MSc med. | telce | 23.01.2009 | 11:34 |
| 3 | 198 | infant med. | telce | 12.01.2009 | 17:36 |
| 6 | 422 | understanding of developing skin med. | telce | 12.01.2009 | 16:51 |
| 1 | 79 | center for hair and skin science med. | telce | 11.01.2009 | 22:36 |
| 1 | 76 | water content med. | telce | 11.01.2009 | 21:37 |
| 5 | 317 | for greater severity pharm. | telce | 27.12.2008 | 14:59 |
| 1 | 163 | safety observations/signals pharm. | telce | 27.12.2008 | 10:55 |
| 1 | 92 | target follow-up med. | telce | 27.12.2008 | 0:36 |
| 4 | 147 | safety concern pharm. | telce | 27.12.2008 | 0:09 |